Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000058 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 16, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
48,520
Total Value
$645,337.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Mar 12, 2026 | Exercise/Conversion | 6,348 | $1.08 | $6,855.84 | 88,837 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 12, 2026 | Sale | 6,348 | $27.37 | $173,747.93 | 82,489 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 13, 2026 | Exercise/Conversion | 3,542 | $10.20 | $36,128.40 | 86,031 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 13, 2026 | Exercise/Conversion | 4,167 | $14.25 | $59,379.75 | 90,198 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 13, 2026 | Sale | 10,726 | $25.91 | $277,922.46 | 79,472 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 13, 2026 | Sale | 3,079 | $27.37 | $84,264.53 | 76,393 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Mar 13, 2026 | Sale | 253 | $27.82 | $7,038.46 | 76,140 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Mar 12, 2026 | Exercise/Conversion | 6,348 | $0.00 | $0.00 | 25,395 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Mar 13, 2026 | Exercise/Conversion | 3,542 | $0.00 | $0.00 | 123,959 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Mar 13, 2026 | Exercise/Conversion | 4,167 | $0.00 | $0.00 | 95,834 | Direct | โ | View Details |